MBCOF (Marvel Biosciences) Ending Cash Position: $0.32 Mil (As of Apr. 2026)


MBCOF Marvel Biosciences Corp MBCOF
34 GF Score
Price $0.11
! 1 Warning Sign
View Full Analysis

What is Marvel Biosciences Ending Cash Position?

Marvel Biosciences MBCOF -7.30% 34 Ending Cash Position is $0.32 Mil as of Apr. 2026. GuruFocus rates MBCOF with a GF Score™ of 34/100. The stock has 1 warning sign investors should review.

Marvel Biosciences's Ending Cash Position for the quarter that ended in Apr. 2026 was $0.32 Mil.

Marvel Biosciences's quarterly Ending Cash Position declined from Oct. 2025 ($0.45 Mil) to Jan. 2026 ($0.20 Mil) but then increased from Jan. 2026 ($0.20 Mil) to Apr. 2026 ($0.32 Mil).

Marvel Biosciences's annual Ending Cash Position declined from Jul. 2023 ($0.42 Mil) to Jul. 2024 ($0.25 Mil) and declined from Jul. 2024 ($0.25 Mil) to Jul. 2025 ($0.09 Mil).

Marvel Biosciences Ending Cash Position Related Terms

Marvel Biosciences Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Marvel Biosciences's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Marvel Biosciences Ending Cash Position Chart

Marvel Biosciences Annual Data
Trend Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
Ending Cash Position
Get a 7-Day Free Trial 1.91 0.46 0.42 0.25 0.09

Marvel Biosciences Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.09 0.45 0.20 0.32
MBCOF
34GF Score
Marvel Biosciences Corp MBCOF
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Marvel Biosciences Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Marvel Biosciences's Ending Cash Position for the fiscal year that ended in Jul. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=0.253+-0.159
=0.09

Marvel Biosciences's Ending Cash Position for the quarter that ended in Apr. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0.2+0.116
=0.32

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $0.32 Mil mean?
Marvel Biosciences (MBCOF) has a Ending Cash Position of $0.32 Mil as of Apr. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Marvel Biosciences and its competitors.
Is Marvel Biosciences' Ending Cash Position too high?
Marvel Biosciences' current Ending Cash Position is $0.32 Mil. Overall, Marvel Biosciences has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Marvel Biosciences' Ending Cash Position compare to VRTX and REGN?
Marvel Biosciences' Ending Cash Position of $0.32 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Biotechnology company?
A good Ending Cash Position depends on the Biotechnology industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Marvel Biosciences and its competitors. Marvel Biosciences's current Ending Cash Position is $0.32 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Marvel Biosciences stock overvalued right now?
Marvel Biosciences (MBCOF) has a current Ending Cash Position of $0.32 Mil. The current Ending Cash Position is $0.32 Mil. Marvel Biosciences' overall GF Score™ is 34/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Marvel Biosciences (MBCOF), the current Ending Cash Position is $0.32 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Marvel Biosciences Business Description

Other Exchanges MRVL:Canada
Address 505 - 8th Avenue SW, Suite 420, Calgary, AB, CAN, T2P1G2
Marvel Biosciences Corp is a biotechnology company incorporated in Canada. The Company is currently a pre-clinical stage pharmaceutical development company that utilizes a drug redevelopment approach to identify and evaluate potential therapeutic compounds. Its activities mainly involve scientific research and pre-clinical studies aimed at determining viable active compounds for further drug development.
34GF Score

Get the complete analysis for MBCOF

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.11
Price